Discontinuation report MYLAN-PRAVASTATIN

Last updated on 2017-09-08 History
Report ID 16148
Drug Identification Number 02257106
Brand name MYLAN-PRAVASTATIN
Common or Proper name PRAVASTATIN
Company Name MYLAN PHARMACEUTICALS ULC
Market Status CANCELLED POST MARKET
Active Ingredient(s) PRAVASTATIN SODIUM
Strength(s) 20MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 100BT
ATC code C10AA
ATC description LIPID MODIFYING AGENTS, PLAIN
Reason for discontinuation Business reasons
Anticipated discontinuation date
Actual discontinuation date 2017-09-07
Remaining supply date 2017-09-07
Discontinuation status Discontinued
Discontinuation decision reversal No
Information on remaining supply The last lot expires on 28-Feb-2018.
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 85 ADVANCE ROAD
ETOBICOKE, ONTARIO
CANADA M8Z 2S6
Company contact information Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v5 2017-09-08 French Compare
v4 2017-09-08 English Compare
v3 2017-09-08 English Compare
v2 2017-07-18 French Compare
v1 2017-07-18 English Compare

Showing 1 to 5 of 5